Skip to main content
Glama

Semanticscholar

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it readOnly, openWorld, idempotent, and non-destructive, but the description adds substantial behavioral context: fan-out across EDGAR, XBRL, USPTO, USaspending, FDA Purple Book, DOL LCA, news, and GLEIF; sources_used/sources_failed semantics; empty sections meaning real 'no data'; soft-fail behavior for patents; FDA small-molecule expected-empty; GDELT→GNews fallback; and resolved:false notes for private companies. This goes far beyond annotation baseline.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with the core purpose and usage guidance. The extended detail on sources, return fields, and edge cases is warranted for a multi-source tool with no output schema. It could benefit from paragraph breaks, but every sentence carries operational meaning.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description bears full responsibility for explaining return values, and it does so comprehensively: resolved_from/resolved_to, filing URIs, fundamentals fields, sources_used/sources_failed, empty-section semantics, FDA no-data expectations, and private-company failure mode with notes. An agent can predict both normal and edge-case results before invoking.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds clarity beyond the schema by explaining that 'type accepts "company" or "ticker" interchangeably — both take the same value shapes,' and by giving concrete ticker, CIK, and company-name examples plus the SEC EDGAR name-resolution behavior. This is valuable but not necessary, since the schema already documents both parameters.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: 'full cross-source profile of a US public company in ONE parallel call.' It also gives concrete user-phrase examples ('Tell me about X', 'brief me on Tesla') and distinguishes itself from single-pack SEC/XBRL/news chaining by emphasizing the holistic cross-source scope.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view,' naming the alternative pattern and the triggering condition. It also sets boundaries: US public companies only, private companies return resolved:false, and person/place support is 'coming soon,' so an agent can decide when not to use it.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Semanticscholar toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have clearly distinct purposes, especially the core ones like get_paper, search_papers, and entity_profile. However, some pairs like ask_pipeworx and ask_pipeworx_grounded, or the polymarket tools, could cause momentary confusion, though descriptions help differentiate.

Naming Consistency2/5

Naming patterns are inconsistent: tools use verb_noun (e.g., get_paper), noun_phrase (e.g., polymarket_arbitrage), and bare verbs (e.g., forget, recall). There is no unifying pattern, and styles like 'pipeworx_feedback' vs 'search_papers' further add to the inconsistency.

Tool Count3/5

With 34 tools, the set covers a broad range of domains (academic papers, company data, prediction markets, memory, subscriptions). While the scope justifies the number, it feels slightly heavy and could benefit from consolidation or clearer grouping.

Completeness4/5

The tool set covers major functionalities for research, data retrieval, and monitoring, with only minor gaps (e.g., limited to US public companies, npm-only dependency scanning). Overall, the surface is comprehensive for the stated capabilities.

Resources